We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
-4.45%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$3.08B
AUM Growth
+$322M
Cap. Flow
+$648M
Cap. Flow %
21%
Top 10 Hldgs %
37.4%
Holding
321
New
89
Increased
78
Reduced
45
Closed
96

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$32M
2
CCCC icon
C4 Therapeutics
CCCC
+$14.5M
3
VRTX icon
Vertex Pharmaceuticals
VRTX
+$14.1M
4
AMRS
Amyris Inc.
AMRS
+$11M
5
TECH icon
Bio-Techne
TECH
+$10.3M

Top Sells

Rank Stock Value
1
NTRA icon
Natera
NTRA
+$14.1M
2
DXCM icon
DexCom
DXCM
+$14.1M
3
ICUI icon
ICU Medical
ICUI
+$14M
4
LIVN icon
LivaNova
LIVN
+$12.2M
5
OLPX
Olaplex Holdings
OLPX
+$11.6M

Sector Composition

Rank Sector Weight
1 Healthcare 24.06%
2 Materials 0.35%
3 Industrials 0.17%
4 Consumer Discretionary 0.07%
5 Financials 0.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PMGMU
301
DELISTED
Priveterra Acquisition Corp. Units
PMGMU
– –
-157,759
Closed -$1.56M
ARYE
302
DELISTED
ARYA Sciences Acquisition Corp V Class A Ordinary Shares
ARYE
– –
-98,980
Closed -$960K
BLU
303
PUT
DELISTED
BELLUS Health Inc.
BLU
– –
-141,700
Closed -$1.14M
OSH
304
PUT
DELISTED
Oak Street Health, Inc.
OSH
– –
-231,600
Closed -$7.67M
SGFY
305
PUT
DELISTED
Signify Health, Inc.
SGFY
– –
-496,700
Closed -$7.06M
SPKBU
306
DELISTED
Silver Spike Acquisition Corp II Units
SPKBU
– –
-77,505
Closed -$771K
LHDX
307
CALL
DELISTED
Lucira Health, Inc. Common Stock
LHDX
– –
-147,800
Closed -$1.27M
ABGI
308
DELISTED
ABG Acquisition Corp. I
ABGI
– –
-116,070
Closed -$1.14M
OYST
309
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
– –
-41,130
Closed -$751K
RACB
310
DELISTED
Research Alliance Corp. II Class A Common Stock
RACB
– –
-503,955
Closed -$4.9M
LOGC
311
DELISTED
LogicBio Therapeutics, Inc. Common Stock
LOGC
– –
-230,121
Closed -$532K
CCXI
312
DELISTED
ChemoCentryx, Inc.
CCXI
– –
-28,118
Closed -$1.02M
RDUS
313
DELISTED
Radius Health, Inc.
RDUS
– –
-124,607
Closed -$862K
SRRA
314
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
– –
-71,320
Closed -$1.55M
ARNA
315
CALL
DELISTED
Arena Pharmaceuticals Inc
ARNA
– –
-291,100
Closed -$27.1M
ARNA
316
DELISTED
Arena Pharmaceuticals Inc
ARNA
– –
-24,361
Closed -$2.26M
ARNA
317
PUT
DELISTED
Arena Pharmaceuticals Inc
ARNA
– –
-97,100
Closed -$9.02M
AVEO
318
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
– –
-123,416
Closed -$579K
9 10 11 12
13

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return
M
MetLife New York $12.3M AUM 29% 1-Year Est. Return

Pura Vida Investments's Q1 2022 Portfolio in Review

As of Q1 2022, Pura Vida Investments held 321 positions worth $3.08B, up 12% from $2.76B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Pura Vida Investments deployed $648M of net new capital in Q1 2022, opening 89 new positions and adding to 78 existing holdings. Its largest new stake was Biogen: 147,135 shares worth $31M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 30% a quarter earlier, followed by Materials and Industrials.

On the sell side, the largest reduction was ICU Medical, an estimated $14M trimmed.

  • Pura Vida Investments's largest Q1 2022 buy was Biogen: 147,135 shares worth $31M.
  • Pura Vida Investments added most to C4 Therapeutics in Q1 2022, an estimated $14.5M increase.
  • Pura Vida Investments's biggest Q1 2022 reduction was ICU Medical, cutting an estimated $14M.
  • Pura Vida Investments fully exited Natera in Q1 2022, selling an estimated $14.1M.
  • Pura Vida Investments's ten largest holdings make up 37% of its $3.08B portfolio in Q1 2022.
  • Pura Vida Investments opened 89 new positions and closed 96 in Q1 2022.
  • Pura Vida Investments's portfolio value rose 12% quarter-over-quarter to $3.08B.

Based on Pura Vida Investments's 13F filing for Q1 2022, filed 16 May 2022.